How many institutions held CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 in Q3 2019?

40 institutional investors reported CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 for Q3 2019. Use the holders table for investor-level position and value details.

Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)

Q: What does CUSIP 15117B202 represent in this 13F holders report?

CUSIP 15117B202 is the security identifier for CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 used to aggregate holder disclosures.

CUSIP: 15117B202

Q3 2019 13F Holders as of 30 Sep 2019

Security type / class: Equity / Common Stock, par value $0.001
Total 13F shares: 3,708,146
Total 13F value: $7,895,004
Share change: +242,068
Put/Call ratio: 60%
SEC-reported price per share: $2.13
Number of holders: 40
Value change: +$465,004
Number of buys: 15
Number of sells: 18
Shares outstanding: 78,103,117

Security key

15117B202

Report period

Q3 2019

Institutions

Top holders

CLDX full security history Ownership snapshot Full 13F holder table Celldex Therapeutics, Inc. SEC filings Celldex Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RENAISSANCE TECHNOLOGIES LLC

Disclosed value leader

RENAISSANCE TECHNOLOGIES LLC

Comparable rows

15/15

Latest evidence

30 Jun 2019

13F Lead comparable stake: 1.2% Showing 1-6 of 15 holder rows.

Quick read

RENAISSANCE TECHNOLOGIES LLC leads the comparable SEC ownership view at 1.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RENAISSANCE TECHNOLOGIES LLC's linked filing trail.

Comparable ownership Top 5

RENAISSANCE TECHNOLOGIES LLC 1.2%

Cresset Asset Management, LLC 0.59%

BlackRock Finance, Inc. 0.44%

DIMENSIONAL FUND ADVISORS LP 0.43%

VANGUARD GROUP INC 0.38%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	1.2%	$2,445,000 912,285 shares	—	30 Jun 2019
Cresset Asset Management, LLC	13F Company 13F	0.59%	$1,227,000 457,666 shares	—	30 Jun 2019
BlackRock Finance, Inc.	13F Company 13F	0.44%	$914,000 340,915 shares	—	30 Jun 2019
DIMENSIONAL FUND ADVISORS LP	13F Company 13F	0.43%	$897,000 334,856 shares	—	30 Jun 2019
VANGUARD GROUP INC	13F Company 13F	0.38%	$800,000 298,674 shares	—	30 Jun 2019
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	0.34%	$718,000 267,557 shares	—	30 Jun 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,708,146

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders

Q3 2019 holders

Holder diff

Investor	Q2 2019 Shares	Q3 2019 Shares	Share Diff	Share Chg %	Q2 2019 value	Q3 2019 value	Value change	Value Chg %